Neoplasia

Journal

Publication Venue For

  • Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer.  21:989-1002. 2019
  • Rectal cancer sub-clones respond differentially to neoadjuvant therapy.  21:1051-1062. 2019
  • A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.  20:894-904. 2018
  • UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.  19:649-658. 2017
  • Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1. Neoplasia. 2015
  • Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia.  17:826-838. 2015
  • Long-term smoking mediated down-regulation of Smad3 induces resistance to carboplatin in non-small cell lung cancer.  14:644-655. 2012
  • Role of transcriptional corepressor CtBP1 in prostate cancer progression.  14:905-914. 2012
  • Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.  14:656-665. 2012
  • Elucidating the mechanism of regulation of transforming growth factor β type II receptor expression in human lung cancer cell lines.  13:912-922. 2011
  • Antibody-based detection of ERG rearrangement-positive prostate cancer.  12:590-598. 2010
  • RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.  11:956-963. 2009
  • Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.  10:1285-1294. 2008
  • Role of the TMPRSS2-ERG gene fusion in prostate cancer.  10:177-188. 2008
  • Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma.  10:1411-1420. 2008
  • Molecular concepts analysis links tumors, pathways, mechanisms, and drugs.  9:443-454. 2007
  • Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.  9:166-180. 2007
  • ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.  8:319-329. 2006
  • Defining aggressive prostate cancer using a 12-gene model.  8:59-68. 2006
  • A specific inhibitor of TGF-β receptor kinase, SB-431542, as a potent antitumor agent for human cancers.  7:509-521. 2005
  • Grape seed proanthocyanidins induce apoptosis through p53, bax, and caspase 3 pathways.  7:24-36. 2005
  • The polycomb group protein EZH2 impairs DNA repair in breast epithelial cells.  7:1011-1019. 2005
  • Exceptionally High Protection of Photocarcinogenesis by Topical Application of (-)-Epigallocatechin-3-Gallate in Hydrophilic Cream in SKH-1 Hairless Mouse Model: Relationship to Inhibition of UVB-Induced Global DNA Hypomethylation.  5:555-565. 2003
  • Suppression of ultraviolet B exposure-mediated activation of NF-κB in normal human keratinocytes by resveratrol.  5:74-82. 2003
  • Synergistic Induction of Cyclooxygenase-2 by Transforming Growth Factor-β1 and Epidermal Growth Factor Inhibits Apoptosis in Epithelial Cells.  1:508-517. 1999
  • p27KIP1 Deletions in Childhood Acute Lymphoblastic Leukemia.  1:253-261. 1999
  • International Standard Serial Number (issn)

  • 0212-9787
  • 1522-8002
  • Electronic International Standard Serial Number (eissn)

  • 1476-5586